Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) is dedicated to supporting innovative projects and programs that enhance the knowledge and understanding of diseases and technological advancements. Their commitment is toward advancing scientific awareness and technologies for public health and welfare in various therapeutic areas of interest. They aim to further scientific progress while ensuring that the projects they support maintain independent control over their goals and dissemination of knowledge.
Summary
Revenue
$1.1b
Number of grants
1
Assets
$158.1m
Median grant size
$1b
Total giving
$1b
Average grant size
$1b
$6billion in active funding & 135k funder profiles from across the country
Sign up to access all foundation profiles
Access thousands of foundation 990 profiles, active grant opportunities, and in-kind donors with your free account